Technical Charts:
Technical Analysis:
Looking at the chart, Wockhardt (CMP:1652) has to sustain above 1625-1640 for an immediate to short term target of 1660-1685-1705-1726 & 1765. Only consecutive closing above 1765, it may target 1815-1860-1925-2000 & 2166-2200-2250 in the mid to long term (bullish case scenario).
On the flip side, inability to sustain above 1625 may drag it to 1610-1599 and sustaining below that it may further fall to 1585-1562-1549-1535-1518-1503 zone. Consecutive closing below 1503, it may further crash to 1485-1450-1401-1386 zone in the near term ( bear case scenario).
Technical Trading Levels (Positional):
|
SL</>10 |
FROM SLR |
|
|
|
|
|
|
|
|
|
|
WOCKPHM |
CMP |
1652 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
T1 |
T2 |
T3 |
T4 |
T5 |
T6 |
T7 |
SLR |
Strong > |
1625 |
|
1640-60* |
1685 |
1705-26* |
1765 |
1815 |
1860 |
1925-2000 |
<1610 |
|
|
|
|
|
|
|
|
|
|
|
Weak < |
1610 |
|
1599-85* |
1562-49 |
1535-18 |
1503* |
1485 |
1450 |
1401-1385 |
>1625 |
|
|
|
|
|
|
|
|
|
|
|
Some Inputs:
Q1FY16 result of Wockhardt is by & large above street estimates due to low base effect and better domestic operations but going forward it has to be compliant with US/UK FDA regulatory environment, which may be quite challenging. So, it will be a high risk play in Wockhardt.
Techno Funda Valuation As Par BG Metrics(Modified):
Current median valuation : 1385
Projected fair valuations: 1700-1975-2250 (FY:16-18)
SCRIP |
EPS(TTM) |
BV(Act) |
P/E(AVG) |
LONG TERM |
SHORT TERM |
MEDIAN VALUE |
200-DEMA |
10-DEMA |
WOCKPHARMA |
36.65 |
333.79 |
36.4 |
1329.44 |
1443.82 |
1386.63 |
1324.84 |
1562.62 |
WOCKPHARMA |
54.45 |
382.25 |
36.4 |
1620.43 |
1759.85 |
1690.14 |
1324.84 |
1562.62 |
WOCKPHARMA |
73.85 |
437.75 |
36.4 |
1887.16 |
2049.52 |
1968.34 |
1324.84 |
1562.62 |
WOCKPHARMA |
96.5 |
501.25 |
36.4 |
2157.23 |
2342.83 |
2250.03 |
1324.84 |
1562.62 |
No comments:
Post a Comment